These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7433716)

  • 1. [Natural and post-vaccination seroconversion for rubella virus among female medical students and women working in the public health institutions].
    Imbs D; Jastrzebska M; Biedrzycka R; Prawecka M; Madaliński K; Michałowicz-Wojczyńska E; Czachorowska M; Szkudlarek D
    Przegl Epidemiol; 1980; 34(2):163-71. PubMed ID: 7433716
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative studies of the immunogenic and reactogenic properties of various vaccines against rubella. I. Seroconversion and post-vaccination reactions in girls immunized against rubella with Almevax vaccine].
    Kańtoch M; Rudnicka H; Imbs D
    Przegl Epidemiol; 1985; 39(3-4):301-8. PubMed ID: 3832164
    [No Abstract]   [Full Text] [Related]  

  • 3. Rubella immune state and rubella vaccination of female university students.
    Nyström M; Peräsalo J
    Scand J Infect Dis; 1984; 16(3):235-9. PubMed ID: 6494810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rubella vaccines and the immunity gap.
    Andre FE; Florent G; du Pan RM
    Lancet; 1979 Aug; 2(8139):417-8. PubMed ID: 89471
    [No Abstract]   [Full Text] [Related]  

  • 5. Rubella specific cell-mediated and humoral immunity following vaccination in college students with low antibody titers.
    Terada K; Itoh Y; Wakabayashi T; Teranishi H; Akaike H; Ogita S; Ouchi K
    Vaccine; 2015 Nov; 33(45):6093-8. PubMed ID: 26275479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of rubella vaccination programme on serological status of young adults in United Kingdom.
    Clarke M; Schild GC; Boustred J; Seagroatt V; Pollock TM; Finlay SE; Barbara JA
    Lancet; 1979 Jun; 1(8128):1224-6. PubMed ID: 87687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutralizing and hemagglutination-inhibiting antibodies to rubella virus as indicators of protective immunity in vaccinees and naturally immune individuals.
    Schluederberg A; Horstmann DM; Andiman WA; Randolph MF
    J Infect Dis; 1978 Dec; 138(6):877-83. PubMed ID: 105058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postinfection and postvaccination antirubella immunity.
    Kańtoch M; Imbs D
    Acta Virol; 1986 Sep; 30(5):381-9. PubMed ID: 2878585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immune response of rubella vaccine in the populations with different age groups].
    Xiong XW; Diao LD; Yan XL
    Zhonghua Liu Xing Bing Xue Za Zhi; 1997 Aug; 18(4):227-9. PubMed ID: 9812525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccines to prevent rubella.
    André FE; Florent G; du Pan RM
    Lancet; 1980 Mar; 1(8169):657-8. PubMed ID: 6102664
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of a two-dose measles, mumps, and rubella vaccination schedule in a cohort of college athletes.
    Coté TR; Sivertson D; Horan JM; Lindegren ML; Dwyer DM
    Public Health Rep; 1993; 108(4):431-5. PubMed ID: 8341775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Rubella virus antibodies among girls and women in Poland].
    Imbs D; Rudnicka H; Prus A
    Przegl Epidemiol; 1980; 34(3):241-7. PubMed ID: 7422904
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevalence of antibodies against rubella virus in Spain.
    Eiros Bouza JM; Luquero Alcalde FJ; Castrodeza Sanz JJ; Bachiller Luque MR; de Lejarazu Leonardo RO
    Clin Infect Dis; 2007 Feb; 44(3):465-6. PubMed ID: 17205464
    [No Abstract]   [Full Text] [Related]  

  • 14. [The rubella immunity survey of unmarried school-aged women in Taipei and feasibility study of rubella vaccination].
    Wu LC; Yen MH; Ng HT; Yuan FJ
    Zhonghua Yi Xue Za Zhi (Taipei); 1987 Sep; 40(3):309-16. PubMed ID: 3502849
    [No Abstract]   [Full Text] [Related]  

  • 15. Rubella-antibodies in school children.
    LaBianca T; LaBianca J; Ibsen KK
    Dan Med Bull; 1985 Oct; 32(5):267-9. PubMed ID: 4053697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative studies of immunogenicity and reactogenicity of various rubella vaccines. II. Seroconversion and post-vaccination reactions in girls immunized against rubella with Rudivax and Cendevax vaccines].
    Imbs D; Kańtoch M; Rudnicka H; Niedźwiedzka-Adamaszek E; Pychyńska A; Zegadło W; Stempień R; Słowińska I; Kretkowska A
    Przegl Epidemiol; 1987; 41(2):141-8. PubMed ID: 3423282
    [No Abstract]   [Full Text] [Related]  

  • 17. [Evaluation of the specific immune response after anti-rubella vaccination].
    Cellesi C; Rossolini A; Rossolini GM; Bianchi Bandinelli ML; Cusi MG; Egisto Valensin P
    Quad Sclavo Diagn; 1988; 24(1-4):97-105. PubMed ID: 3268925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroepidemiologic study of rubella in selected Chinese female.
    Yuan C; Ng HT; Hu MM; Liu WT
    Zhonghua Yi Xue Za Zhi (Taipei); 1989 Feb; 43(2):85-8. PubMed ID: 2766071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral immune response after primary rubella virus infection and after vaccination.
    Vauloup-Fellous C; Grangeot-Keros L
    Clin Vaccine Immunol; 2007 May; 14(5):644-7. PubMed ID: 17344342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pre and post-vaccinal rubella seroepidemiology in Brittany (1971-1975). Comparative study of Cendehill and Plotkin's strains].
    Zou J; Senecal J; Morvan A; Roussey A
    Ann Pediatr (Paris); 1976 Feb; 23(2):111-8. PubMed ID: 16104238
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.